Lumbrokinase vs Nattokinase: Key Differences

Enzyme-based therapies have gained increasing attention for their ability to support cardiovascular health through natural mechanisms. 

Among these, fibrinolytic enzymes stand out for their role in breaking down fibrin, a protein involved in blood clot formation and arterial plaque structure. Two of the most widely discussed options are lumbrokinase and nattokinase, both known for their effects on circulation and vascular function.

Understanding the differences between these two enzymes is essential for selecting the most appropriate option. While they share a similar goal - supporting healthy blood flow and reducing clot-related risks - their origins, mechanisms, and ideal use cases differ significantly. 

This distinction becomes especially important when considering long-term cardiovascular maintenance versus targeted intervention.

What Is Nattokinase and What Does Nattokinase Do?

Nattokinase is a proteolytic enzyme extracted from natto, a traditional Japanese food made by fermenting soybeans with Bacillus subtilis. It has been consumed for centuries and is associated with the cardiovascular health often observed in populations that regularly include natto in their diet.

The primary function of nattokinase is to break down fibrin, a protein that plays a central role in blood clot formation and contributes to the structural integrity of arterial plaque. By supporting the body’s natural fibrinolytic processes, nattokinase helps maintain smoother blood flow and reduces excessive clot formation. This mechanism makes it particularly valuable for long-term vascular health.

In addition to fibrin degradation, nattokinase has been shown to support several important physiological processes:

• Enhancement of plasmin activity, the body’s natural clot-dissolving enzyme

• Improvement in blood viscosity and circulation

• Support for healthy blood pressure through vascular relaxation

• Contribution to arterial flexibility and reduced stiffness

Over time, these effects may contribute to improved cardiovascular resilience. Unlike more aggressive interventions, nattokinase works gradually, making it well suited for consistent, daily use. 

High-potency formulations such as Healthletic’s Nattokinase, which delivers a clinical-strength 10,800 FU dose, are designed to go beyond basic maintenance and actively support arterial health at a deeper level.

What Is Lumbrokinase?

Lumbrokinase is a group of enzymes derived from earthworms, specifically Lumbricus rubellus. It has been used in traditional medicine systems and is increasingly studied for its potent fibrinolytic properties. Compared to nattokinase, lumbrokinase is considered more aggressive in its action.

The primary mechanism of lumbrokinase involves direct degradation of fibrin. While nattokinase enhances the body’s natural processes, lumbrokinase acts more directly on fibrin structures, breaking them down with higher intensity. 

This makes it particularly relevant in situations where rapid or targeted fibrin reduction is desired.

Lumbrokinase is often associated with more specialized use cases, including:

• Circulatory disorders requiring targeted intervention

• Support in individuals with elevated clotting risk

• Post-event recovery protocols under medical supervision

Despite its strength, lumbrokinase is less commonly used as a daily supplement. Its potency requires more careful dosing and oversight, and it is typically recommended in practitioner-guided protocols rather than general wellness routines.

Lumbrokinase vs Nattokinase: Key Differences

Both enzymes play a role in fibrin management, but their applications differ. Nattokinase provides a balanced and sustainable approach, while lumbrokinase delivers a more intense effect that may not be necessary for most individuals.

How They Work in the Body

Nattokinase Mechanism

Nattokinase works by enhancing the body’s endogenous fibrinolytic system. It increases the activity of plasmin, the enzyme responsible for breaking down fibrin, while also reducing levels of plasminogen activator inhibitor-1 (PAI-1), which can limit fibrinolysis.

This indirect mechanism allows nattokinase to:

• Promote steady fibrin breakdown

• Support healthy circulation without excessive disruption

• Improve endothelial function and nitric oxide production

Because it aligns with the body’s natural processes, nattokinase is well tolerated and suitable for long-term use. Over time, consistent supplementation can contribute to improved vascular flexibility and more efficient blood flow.

Lumbrokinase Mechanism

Lumbrokinase operates through a more direct enzymatic pathway. It actively degrades fibrin without relying as heavily on the body’s regulatory systems. This results in a faster and more pronounced effect on clot-related structures.

Its mechanism includes:

• Direct enzymatic breakdown of fibrin strands

• Potential activation of additional fibrinolytic pathways

• Rapid reduction of fibrin accumulation

While effective, this level of activity requires careful consideration. The stronger action of lumbrokinase may increase the risk of excessive fibrinolysis if not properly managed, which is why it is often reserved for targeted use.

Benefits of Nattokinase vs Lumbrokinase

Benefits of Nattokinase

Nattokinase offers a broad range of cardiovascular benefits that extend beyond simple clot reduction. Its gradual and systemic effects make it a valuable tool for maintaining long-term vascular health.

Key benefits include:

• Support for healthy blood pressure levels

• Improved circulation and oxygen delivery

• Reduction in arterial stiffness

• Support for balanced cholesterol dynamics

• Long-term cardiovascular protection

By addressing fibrin buildup, nattokinase helps reduce the structural foundation of plaque formation. 

Advanced formulations such as Healthletic’s Nattokinase are specifically designed to target arterial inflammation and fibrin accumulation, supporting both prevention and active improvement.

Benefits of Lumbrokinase

Lumbrokinase is primarily valued for its potency. Its benefits are more focused and typically applied in situations where stronger intervention is required.

These include:

• Rapid fibrin degradation

• Support in high-risk clotting conditions

• Use in specialized therapeutic protocols

While effective, its narrower application makes it less suitable for general wellness. It is most beneficial when used strategically under professional guidance.

Which Is Better: Nattokinase vs Lumbrokinase?

The choice between nattokinase and lumbrokinase depends largely on the intended goal. Each enzyme serves a distinct purpose, and selecting the right one requires understanding the context of use.

Nattokinase is generally the preferred option for individuals seeking:

• Daily cardiovascular support

• Improved circulation and blood pressure regulation

• Long-term arterial health maintenance

• A preventive approach to vascular aging

Lumbrokinase, on the other hand, may be more appropriate for:

• Targeted fibrin reduction

• Short-term or intensive protocols

• Situations requiring stronger enzymatic activity

For most individuals, nattokinase provides a more practical and sustainable solution. Its safety profile, combined with extensive research and suitability for daily use, makes it the better choice for ongoing cardiovascular support.

Can You Take Nattokinase and Lumbrokinase Together?

Combining nattokinase and lumbrokinase is technically possible, but it requires caution. Both enzymes influence fibrinolysis, and their combined effects may amplify the breakdown of fibrin beyond intended levels.

This combination may increase the risk of:

• Excessive bleeding

• Bruising

• Interactions with medications

For this reason, concurrent use should only be considered under professional supervision. In most cases, using a single, well-formulated enzyme is sufficient to achieve desired outcomes.

Why Nattokinase Is the Preferred Daily Solution

Nattokinase stands out as the more practical choice for long-term cardiovascular health. Its balanced mechanism allows it to support multiple aspects of vascular function without overwhelming the body’s natural systems.

Key advantages include:

• Extensive clinical research and historical use

• Compatibility with daily supplementation

• Broad cardiovascular benefits beyond fibrin breakdown

• Lower risk profile compared to more aggressive enzymes

Consistent use of a high-quality formulation can provide cumulative benefits over time. Healthletic’s Nattokinase is designed with this approach in mind, delivering a clinically relevant dose that supports circulation, arterial flexibility, and overall cardiovascular resilience.

Final Verdict

Lumbrokinase and nattokinase both offer valuable benefits, but their roles are distinct. Lumbrokinase provides strong, targeted fibrin degradation suited for specific situations, while nattokinase delivers a more balanced and sustainable approach.

For most individuals, nattokinase is the superior option. Its ability to support long-term cardiovascular health, combined with its safety and versatility, makes it the preferred choice for daily use. 

When formulated at an effective dose, it offers a comprehensive solution for maintaining healthy circulation and reducing the impact of fibrin buildup.

Here are your expanded FAQ answers, each written as a full paragraph while keeping clarity and SEO strength:

Frequently Asked Questions

What does nattokinase do exactly?

Nattokinase is a fibrinolytic enzyme that primarily works by breaking down fibrin, a protein involved in blood clot formation and the structural framework of arterial plaque. By supporting the body’s natural clot-dissolving processes, it helps maintain smoother blood flow and reduces blood viscosity. 

In addition to fibrin degradation, nattokinase may enhance circulation, support healthy blood pressure levels, and contribute to improved vascular flexibility. 

Is lumbrokinase stronger than nattokinase?

Lumbrokinase is generally considered stronger than nattokinase because it acts more directly on fibrin, leading to faster and more pronounced breakdown. This direct enzymatic action can make it effective in targeted or short-term applications where aggressive fibrin reduction is needed.

However, greater strength does not necessarily translate to better outcomes for everyday use. Nattokinase offers a more balanced and gradual approach, making it better suited for long-term cardiovascular support, while lumbrokinase is often reserved for more specific or practitioner-guided protocols.

Can nattokinase dissolve plaque?

Nattokinase does not directly remove plaque in the same way a medical procedure would, but it plays an important role in breaking down the fibrin matrix that helps stabilize plaque within arterial walls. By reducing this fibrin structure, nattokinase may support the body’s natural ability to gradually improve arterial condition over time. 

This process can contribute to better circulation and reduced arterial stiffness when combined with consistent use and healthy lifestyle habits. Higher-potency formulations are often used when the goal is to support more active changes in vascular health.

Is nattokinase safe daily?

Nattokinase is generally considered safe for daily use in most healthy individuals when taken at appropriate doses. It has a long history of use in traditional diets and is supported by modern research for its cardiovascular benefits.

However, because it influences blood clotting pathways, individuals who take anticoagulant medications, have bleeding disorders, or are preparing for surgery should consult a healthcare provider before using it. 

When used responsibly and with proper guidance if needed, nattokinase can be a well-tolerated and effective addition to a long-term cardiovascular support routine.

References

• Li, X., Long, J., Gao, Q., Pan, M., Wang, J., Yang, F., & Zhang, Y. (2023). Nattokinase supplementation and cardiovascular risk factors: a systematic review and meta-analysis of randomized controlled trials. Reviews in Cardiovascular Medicine, 24(8), 234. Link.

• Wiyarta, E., Hidayat, R., Kurniawan, M., Saputro, B. I. L., Maharani, I. L., Rampengan, D. D. C. H., ... & Tjandrawinata, R. R. (2025). Therapeutic Potential of Lumbrokinase in Acute Ischemic Stroke: A Meta-Analysis of Efficacy and Safety. Therapeutics and Clinical Risk Management, 1319-1331. Link.